iDEL Therapeutics GmbH | $10,381,635 | (Mar 18, 2026)
Surf AI(1) | $57,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Certified by Founder
Lodge
Raylo
start up
United Kingdom
- London, London
- 31/01/2023
- Unknown
- $136,000,000
We are a subscription payment platform leading the change in the way products are sold and enjoyed.
Retailers who add Raylo Pay to their checkout can offer consumers the products they love on flexible, low monthly subscriptions, and Raylo Pay’s zero fees mean retailers are paid in full upfront, risk-free.
When consumers subscribe rather than buy, Raylo’s circular model ensures every product gets an extended life through our automatic cycle of refurb and reuse.
Raylo is backed by Octopus Ventures, Macquarie, Telefónica and Techstart Ventures.
- Industry Financial Services
- Website http://www.raylopay.com/
- LinkedIn https://www.linkedin.com/company/raylo/
Quorus | $5,000,000 | (Mar 18, 2026)
BambooBox | $6,600,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
SEQUENTIAL | $3,500,000 | (Mar 18, 2026)
Standard Template Labs | $49,000,000 | (Mar 18, 2026)
Tenkara | $7,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
Malama Health | $9,200,000 | (Mar 17, 2026)
AgZen | $10,000,000 | (Mar 17, 2026)